Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

In SIV infection, gut integrity is retained, not repaired

March 12, 2020

Gilead presents 96-week data from DISCOVER trial of Descovy for PrEP

March 11, 2020

Broadly neutralizing antibody plus latency reversing treatment evaluated in HIV trial

March 11, 2020

Encouraging 48-week data from phase III ATLAS-2M study of long-acting HIV regimen

March 10, 2020

CROI in the time of COVID-19: Researchers phoning it in at all-virtual 2020 CROI

March 10, 2020

New phase III trials evaluate switch to doravirine/islatravir in HIV patients on other regimens

March 3, 2020

ViiV Healthcare presents new antivirals for HIV infection

Feb. 27, 2020

GlaxoSmithKline and ViiV Healthcare present compounds for HIV infection

Feb. 25, 2020

New HDAC inhibitors disclosed by Merck & Co.

Feb. 20, 2020

TaiMed studies TMB-365 in first-in-human trial for HIV-1

Feb. 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026